U.S. District Court Decision About Eisai's Action Over Aricept Filing

Eisai Co., Ltd. and Eisai Inc. filed a lawsuit in August 2006 against Mutual Pharmaceutical Co., Inc. and United Research Laboratories, Inc. claiming that its submission of an abbreviated new drug application (ANDA) to the U.S. Food and Drug Administration (FDA) for Aricept ODT (donepezil hydrochloride orally disintegrating tablets) would infringe Eisai’s composition of matter patent.
Fox Business